In some tumours such as breast cancer, however, low Prrx1 levels were associated with metastasis and poor prognosis in clinical samples 10, whereas in colorectal adenocarcinomas abundant Prrx1 expression was associated with metastasis and poor prognosis 13. This evidence concerns the gene PRRX1 and colorectal adenocarcinoma.